Argan awards CEO Collins new stock and RSU grants
Argan Inc. granted equity awards to Charles Edwin Collins IV, Chief Executive Officer of Gemma.
Rhea-AI Filing Summary
Argan Inc. granted equity awards to Charles Edwin Collins IV, Chief Executive Officer of Gemma. On April 8, 2026, he received 10-year options for 332 shares of common stock at an exercise price of $588.28 per share, vesting ratably over three years starting April 8, 2027.
He was also granted 231 time-based RSUs that vest in three equal annual installments from April 8, 2027. In addition, he received performance-based RSUs with a target of 170 shares tied to three-year relative total stock return versus 12 peers, and EPS-based RSUs with a target of 2,618 shares tied to compounded EPS growth over fiscal 2027–2029.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 3,351 shares
Grant/Award
4 txns
Insider
Collins Charles Edwin IV
Role
CHIEF EXECUTIVE OFFICER, GEMMA
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Option to Purchase Common Stock | 332 | $0.00 | $0.00 |
| Grant/Award | Time Based Restricted Stock Units | 231 | $0.00 | $0.00 |
| Grant/Award | Performance Based Restricted Stock Units | 170 | $0.00 | $0.00 |
| Grant/Award | Earnings Per Share Performance Based Restricted Stock Units | 2,618 | $0.00 | $0.00 |
Holdings After Transaction:
Option to Purchase Common Stock — 15,067 contracts (Direct);
Time Based Restricted Stock Units — 6,564 contracts (Direct);
Performance Based Restricted Stock Units — 2,670 contracts (Direct);
Earnings Per Share Performance Based Restricted Stock Units — 10,118 contracts (Direct)
Footnotes (4)
- F1. On April 8, 2026, the Reporting Person received 10-year options to purchase 332 shares of the Issuer's common stock with an exercise price of $588.28 per share. The options will vest ratably over three years on each anniversary of the grant date starting on 4/8/2027.
- F2. On April 8, 2026 the Reporting Person was granted Time-Based Restricted Stock Units ("TRSUs") covering 231 shares of common stock. The TRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 4/8/2027.
- F3. On April 8, 2026, the Reporting Person was granted Performance-Based Restricted Stock Units ("PRSUs") in the target number of 170 shares, the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2026 Proxy Statement. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the target number of 170 shares, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.
- F4. On April 8, 2026, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 2,618 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2027, 2028 and 2029 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2024, 2025 and 2026. The pay-out ratio of the target number of 2,618 shares, ranging from 0% to 200%, will depend on the degree of achievement of the EPS ranking at the end of the three-year performance period.
Key Figures
Stock options granted: 332 options at $588.28/share
Time-based RSUs granted: 231 RSUs
TSR performance RSUs target: 170 RSUs (0–200% payout)
+5 more
8 metrics
Stock options granted
332 options at $588.28/share
10-year options granted April 8, 2026, vest over three years
Time-based RSUs granted
231 RSUs
TRSUs vest in three equal installments starting April 8, 2027
TSR performance RSUs target
170 RSUs (0–200% payout)
Tied to three-year total stock return vs 12 peers
EPS performance RSUs target
2,618 RSUs (0–200% payout)
Based on EPS sums for FY 2027–2029 vs FY 2024–2026
Options held after grant
15,067 options
Total stock options following April 8, 2026 grant
Time-based RSUs held after grant
6,564 RSUs
Total TRSUs following April 8, 2026 grant
Performance RSUs held after grant
2,670 RSUs
Total PRSUs following April 8, 2026 grant
EPS performance RSUs held after grant
10,118 RSUs
Total EPSRSUs following April 8, 2026 grant
Key Terms
Restricted Stock Units, Performance-Based Restricted Stock Units, Total Stock Return, Earnings Per Share, +1 more
5 terms
Restricted Stock Units financial
"Time-Based Restricted Stock Units ("TRSUs") covering 231 shares of common stock."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Performance-Based Restricted Stock Units financial
"Performance-Based Restricted Stock Units ("PRSUs") in the target number of 170 shares, the vesting of which is subject to the rank of the Total Stock Return"
Performance-based restricted stock units are a type of employee equity award that converts into company shares only if predefined financial or operational targets are met over a set period. Think of it like a bonus check that becomes stock only when specific goals are hit; it ties pay to results, aligning managers’ incentives with shareholders. Investors care because these awards affect future share count, executive incentives, and signal how management’s success will be measured and rewarded.
Total Stock Return financial
"subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period"
Total stock return measures the complete gain or loss an investor gets from owning a share over a set period, combining changes in the stock price with any cash payouts such as dividends, and is usually shown as a percentage. It matters because it gives a fuller picture of performance than price alone—like comparing a car’s change in resale value plus the money you earned by renting it out—to help investors compare and evaluate investments.
compounded growth EPS financial
"compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2024, 2025 and 2026"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Argan (AGX) grant to Charles Edwin Collins IV?
Argan granted Collins options on 332 shares, 231 time-based RSUs, 170 performance-based RSUs, and 2,618 EPS performance-based RSUs. These awards are part of his equity compensation and vest over multi-year periods tied to time and performance conditions.
How do the new stock options for Argan (AGX) executive Collins work?
Collins received 10-year options to purchase 332 Argan common shares at $588.28 per share. The options vest ratably over three years, with one-third vesting on each anniversary of the April 8, 2026 grant date starting April 8, 2027, if service conditions are met.
What are the terms of the time-based RSUs granted by Argan (AGX)?
Collins was granted 231 time-based restricted stock units covering Argan common shares. These TRSUs vest in three equal annual installments on each of the next three anniversaries of the April 8, 2026 grant date, beginning April 8, 2027, contingent on continued service.
How are the performance-based RSUs for Argan (AGX) executive Collins structured?
He received performance-based RSUs with a target of 170 shares, linked to Argan’s total stock return over three years versus 12 peer companies. The payout ratio ranges from 0% to 200% of the target, based on the final TSR ranking at the end of the performance period.
How will Collins’ EPS-based RSUs from Argan (AGX) vest?
Collins’ 2,618 EPS performance-based RSUs vest based on the sum of earnings per share for fiscal 2027, 2028 and 2029 compared with target compounded EPS growth derived from fiscal 2024–2026. The payout can range from 0% to 200% of the 2,618 target shares.
What are Collins’ derivative holdings after these Argan (AGX) grants?
Following the grants, Collins holds 15,067 options to purchase common stock, 6,564 time-based RSUs, 2,670 performance-based RSUs, and 10,118 EPS performance-based RSUs. These totals reflect cumulative derivative holdings of each award type after the April 8, 2026 transactions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
